Morgan Stanley’s BIMI International Medical Inc. Common Stock BIMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6
Closed -$3 7718
2023
Q1
$3 Hold
6
﹤0.01% 7693
2022
Q4
$7 Sell
6
-1
-14% -$2 ﹤0.01% 7822
2022
Q3
$0 Sell
7
-65
-90% -$318 ﹤0.01% 7955
2022
Q2
$0 Buy
72
+65
+929% +$511 ﹤0.01% 8055
2022
Q1
$0 Sell
7
-40
-85% -$653 ﹤0.01% 8180
2021
Q4
$1K Buy
+47
New +$1.68K ﹤0.01% 7896
2019
Q4
Sell
-2
Closed 6807
2019
Q3
$0 Sell
2
-18
-90% -$1.87K ﹤0.01% 6799
2019
Q2
$2K Sell
20
-1,350
-99% -$245K ﹤0.01% 6482
2019
Q1
$425K Buy
1,370
+380
+38% +$168K ﹤0.01% 4642
2018
Q4
$779K Buy
990
+986
+24,650% +$418K ﹤0.01% 4473
2018
Q3
$1K Sell
4
-183
-98% -$39.2K ﹤0.01% 6663
2018
Q2
$25K Buy
187
+183
+4,575% +$20.3K ﹤0.01% 6099
2018
Q1
$0 Hold
4
﹤0.01% 6725
2017
Q4
$0 Buy
+4
New +$197 ﹤0.01% 6680
2016
Q2
Hold
0
6690
2016
Q1
Hold
0
6751
2015
Q4
Hold
0
6830
2015
Q3
Hold
0
6753
2015
Q2
Hold
0
6777
2015
Q1
Hold
0
6681
2014
Q4
Hold
0
6693
2014
Q3
Hold
0
6679
2014
Q2
Hold
0
6617
2014
Q1
Hold
0
6559

Other funds holding BIMI

Morgan Stanley's BIMI Position: Q2 2023 in Review

Morgan Stanley sold out of BIMI International Medical Inc. Common Stock (BIMI) in Q2 2023, closing a stake of 6 shares — an estimated $3 sold.

Morgan Stanley first reported a position in BIMI in Q4 2017 and held it in 14 quarters. The position peaked at $779K in Q4 2018. 5 funds tracked by Wall St. Rank hold BIMI as of Q2 2023.

  • Morgan Stanley reported no remaining BIMI International Medical Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Morgan Stanley sold 6 BIMI International Medical Inc. Common Stock shares in Q2 2023, an estimated $3.
  • Morgan Stanley first reported a position in BIMI International Medical Inc. Common Stock in Q4 2017 and held it in 14 quarters.
  • Morgan Stanley's BIMI International Medical Inc. Common Stock position peaked at $779K in Q4 2018.
  • 5 funds tracked by Wall St. Rank held BIMI International Medical Inc. Common Stock as of Q2 2023.

Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.